Similar articles

• [Cutaneosystemic congenital mastocytosis].

  Labeille B, Kremp O, Lok C, Teillac D, Risbourg B, Denoeux JP, de Prost Y. Labeille B, et al. Ann Dermatol Venereol. 1990;117(11):805-6. Ann Dermatol Venereol. 1990. PMID: 2099685 French. No abstract available.
• Systemic mastocytosis: management of an unusual case with histamine (H1 and H2) antagonists and cyclooxygenase inhibition.

  Crawhall JC, Wilkinson RD. Crawhall JC, et al. Clin Invest Med. 1987 Jan;10(1):1-4. Clin Invest Med. 1987. PMID: 2880686
• [Systemic mastocytosis].

  Sade K, Dotan I, Levo Y. Sade K, et al. Harefuah. 2000 Sep;139(5-6):202-6, 245. Harefuah. 2000. PMID: 11062953 Hebrew.
• Mast Cells, Mastocytosis, and Related Disorders.

  Theoharides TC, Valent P, Akin C. Theoharides TC, et al. N Engl J Med. 2015 Jul 9;373(2):163-72. doi: 10.1056/NEJMra1409760. N Engl J Med. 2015. PMID: 26154789 Review. No abstract available.
• The treatment of mastocytosis: an overview.

  Metcalfe DD. Metcalfe DD. J Invest Dermatol. 1991 Mar;96(3 Suppl):55S-56S; discussion 56S-59S, 60S-65S. doi: 10.1111/1523-1747.ep12469049. J Invest Dermatol. 1991. PMID: 16799611 Review.